Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Is Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?
Is Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?
Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know
Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know
New Strong Sell Stocks for March 18th
Brokers Suggest Investing in Amphastar (AMPH): Read This Before Placing a Bet
Brokers Suggest Investing in Amphastar (AMPH): Read This Before Placing a Bet
Amphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Shares
Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Apple, Microsoft, Oracle, Arm, Rivian, Lyft & more
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.